Form 8-K · Current report
McKesson Corporation 8-K, filed Jul 24, 2026
- Filed
- CIK
- 0000927653
- Accession no.
- 0000927653-26-000215
Summary
McKesson Corporation shareholders elected all eleven board-nominated director candidates, ratified Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending March 31, 2027, and approved on an advisory basis the compensation of its named executive officers at the annual meeting held July 22, 2026.
Key points
- The advisory say-on-pay proposal received 86,580,776 votes for, 7,732,776 against, and 387,199 abstentions.
- Ratification of Deloitte & Touche LLP drew 95,066,170 votes for and 9,872,183 against.
- Among director nominees, Brian S. Tyler received the lowest support with 86,826,318 votes for and 7,758,777 against; Maria N. Martinez had the next lowest at 88,547,303 for and 5,963,501 against.
- Each director nominee was elected by majority of votes cast, with abstentions and broker non-votes not counted.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.07Submission of Matters to a Vote of Security Holders
From the filing
Item 5.07 Submission of Matters to a Vote of Security Holders On July 22, 2026, McKesson Corporation (“Company”) held its Annual Meeting of Shareholders. Shown below are the final vote results on each of the items submitted to a vote and described in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 12, 2026. Item 1. Each of the following individuals nominated by the Board of Directors was elected to serve as a director, having received the following votes:1 Director Nominee Votes For Votes Against Abstentions Broker Non-Votes Dominic J. Caruso 93,233,995 1,284,036 182,720 10,458,484 Lynne M. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.